Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Nicolas, Marcoux"'
Autor:
Hagit Peretz Soroka, Tushar Vora, Jonathan Noujaim, Nicolas Marcoux, Sarah Cohen‐Gogo, Thierry Alcindor, Caroline Holloway, Caroline Rodrigues, Hatim Karachiwala, Saima Alvi, Ursula Lee, Sylvia Cheng, Shantanu Banerji, Sapna Oberoi, Xiaolan Feng, Alannah Smrke, Christine Simmons, Albiruni Abdul Razak, Abha A. Gupta
Publikováno v:
Cancer Medicine, Vol 12, Iss 18, Pp 18872-18881 (2023)
Abstract Objectives We conducted a retrospective multi‐centre study to assess the real‐world outcome of regorafenib (REGO) and cabozantinib (CABO) in recurrent/refractory bone tumours (BTs) including osteosarcoma (OST), Ewing sarcoma (EWS) and ch
Externí odkaz:
https://doaj.org/article/77f0759b62cf455bb618ca80b59f6638
Autor:
Nidal El Yamani, Gabrielle Cote, Julie Riopel, Nicolas Marcoux, Fabrice Mac-Way, David Philibert, Mohsen Agharazii
Publikováno v:
Kidney Medicine, Vol 5, Iss 8, Pp 100682- (2023)
Immune checkpoint inhibitors are known to have a wide range of autoimmune toxicities, such as acute interstitial nephritis. Immunotherapy induced glomerulonephritis has been described, but anti-glomerular basement membrane disease (anti-GBM) is rarel
Externí odkaz:
https://doaj.org/article/0467b9763f55404e94c8ae21c2b292a1
Autor:
Alexis V. Rioux, Julie Riopel, Nicolas Marcoux, Catherine Thériault, Peter V. Gould, Alexandre P. Garneau, Paul Isenring
RMND1 has been identified as a mitochondriopathy-associated gene less than 12 years ago. The most common phenotype related to this gene is an early onset, severe form of encephalomyopathy that leads to death in a medium time of three years after birt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1a29f8e64d9d44cc8cd8eb4eacb76cf
https://doi.org/10.21203/rs.3.rs-2838684/v1
https://doi.org/10.21203/rs.3.rs-2838684/v1
Autor:
Lecia V. Sequist, Aaron N. Hata, Beni Wolf, Sai-Hong I. Ou, Corinne Clifford, Erica K. Evans, Alice T. Shaw, Rebecca S. Heist, A. John Iafrate, Mari Mino-Kenudson, Dora Dias-Santagata, Richard B. Lanman, Rebecca J. Nagy, Jessica J. Lin, Varuna Nangia, Amanda K. Riley, Satoshi Yoda, Wenjia Su, Subba R. Digumarthy, Mandeep K. Banwait, Nicolas Marcoux, Viola W. Zhu, Inga T. Lennes, Justin F. Gainor, Jochen K. Lennerz, Hideko Isozaki, Zofia Piotrowska
Supplementary Data and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc96358440634edc76f9afcf0d045e29
https://doi.org/10.1158/2159-8290.22534325.v1
https://doi.org/10.1158/2159-8290.22534325.v1
Autor:
Lecia V. Sequist, Aaron N. Hata, Beni Wolf, Sai-Hong I. Ou, Corinne Clifford, Erica K. Evans, Alice T. Shaw, Rebecca S. Heist, A. John Iafrate, Mari Mino-Kenudson, Dora Dias-Santagata, Richard B. Lanman, Rebecca J. Nagy, Jessica J. Lin, Varuna Nangia, Amanda K. Riley, Satoshi Yoda, Wenjia Su, Subba R. Digumarthy, Mandeep K. Banwait, Nicolas Marcoux, Viola W. Zhu, Inga T. Lennes, Justin F. Gainor, Jochen K. Lennerz, Hideko Isozaki, Zofia Piotrowska
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00e051601bd88ba6af4840dc715298fa
https://doi.org/10.1158/2159-8290.22534322.v1
https://doi.org/10.1158/2159-8290.22534322.v1
Autor:
Andree-Anne Pelland, Xavier Savard, Frederic Barabe, Vincent Laroche, Michaël Munger, Genevieve Gallagher, Nicolas Marcoux, Guy Cantin, Maxime Chénard-Poirier, Robert Delage, Marc Lalancette, Christopher Lemieux
Publikováno v:
Blood. 140:3304-3305
Autor:
Victor Cohen, Chloé Charbonneau, Rui Kitadai, Lena Cvetkovic, Penelope A. Bradbury, Normand Blais, Julie Malo, Marie Florescu, Félix Blanc-Durand, S. Lau, Wiam Belkaid, Natasha B. Leighl, Arielle Elkrief, Adrian G. Sacher, Corentin Richard, Kevin Jao, Suzanne Kazandjian, Geoffrey Liu, Mustapha Tehfe, Taiki Hakozaki, Frances A. Shepherd, Jason Agulnik, Nathalie Daaboul, Benjamin Shieh, S. Owen, Houda Bahig, Nicolas Marcoux, Meriem Messaoudene, Bertrand Routy, Antoine Desilets
Publikováno v:
European Journal of Cancer. 142:83-91
The PACIFIC trial demonstrated that durvalumab therapy following chemoradiation (CRT) was associated with improved overall survival (OS) in patients with stage III non-small cell lung cancer (NSCLC). It is unclear whether the results obtained as part
Autor:
Tushar Shailesh Vora, Hagit Peretz Soroka, Jonathan Christopher Noujaim, Nicolas Marcoux, Thierry Alcindor, Hatim Karachiwala, Saima Alvi, Furqan Shaikh, Albiruni Ryan Abdul Razak, Abha A. Gupta
Publikováno v:
Journal of Clinical Oncology. 40:11530-11530
11530 Background: Survival after relapse in osteosarcoma (OST), Ewing Sarcoma (ES) and chondrosarcoma (CS) remains dismal. Recent reports suggest a role of tyrosine kinase inhibitors (TKI) including regorafenib (R) and cabozantinib (C). We conducted
Autor:
Alice T. Shaw, Jochen K. Lennerz, Mari Mino-Kenudson, Hideko Isozaki, Subba R. Digumarthy, Inga T. Lennes, Rebecca J. Nagy, Corinne Clifford, Aaron N. Hata, Jessica J. Lin, Lecia V. Sequist, Mandeep Banwait, Amanda K. Riley, Dora Dias-Santagata, Justin F. Gainor, Zofia Piotrowska, Sai-Hong Ignatius Ou, Varuna Nangia, Viola W. Zhu, Rebecca S. Heist, Richard B. Lanman, Nicolas Marcoux, Wenjia Su, A. John Iafrate, Satoshi Yoda, Erica Evans, Beni B. Wolf
Publikováno v:
Cancer Discovery. 8:1529-1539
We present a cohort of 41 patients with osimertinib resistance biopsies, including 2 with an acquired CCDC6–RET fusion. Although RET fusions have been identified in resistant EGFR-mutant non–small cell lung cancer (NSCLC), their role in acquired
Autor:
Meghan J. Mooradian, Zofia Piotrowska, Konstantinos Arnaoutakis, Rebecca J. Nagy, Mari Mino-Kenudson, Anna F. Farago, Dora Dias-Santagata, Benjamin J. Drapkin, Lecia V. Sequist, Aaron N. Hata, Richard B. Lanman, Nicolas Marcoux, Anthony J. Iafrate
Publikováno v:
JCO Precision Oncology. :1-7